The use of half dose gadolinium coupled with artificial intelligence algorithms is effective in visualizing primary and metastatic disease to the brain and reduces gadolinium retention concerns. There is potential cost savings from the use of lower dose gadolinium.
This abstract and the presentation materials are available to members only; a login is required.